2020 AAN Highlights Jak mění malá molekula průběh spinální svalové atrofie?
|Title in English||2020 AAN Highlights How does a small molecule change the course of spinal muscle atrophy?|
|Year of publication||2020|
|Type||Article in Periodical (without peer review)|
|MU Faculty or unit|
|Description||Communication of prof. Servaise on the first results achieved with risdiplam in the treatment of infants with spinal muscular atrophy (SMA) type I was originally accepted into the main program of this year's annual American Academy of Neurology Congress. After the congress had to be moved to virtual space due to the COVID-19 pandemic, it was heard during a webcast broadcast on April 28.|